Technological trends overview for medicines available for the treatment of tuberculosis in Mozambique and Brazil

Abstract

This study aims to investigate the medications available for the treatment of Tuberculosis (TB) in Mozambique and Brazil, and analyzes innovations related to patents at both the global and national levels. The approach used was exploratory and analytical, employing consultations of indexed databases, official government agencies, and the Derwent Innovation® database. The work highlights the reflection on TB, considered a critical global public health issue characterized by high morbidity and mortality rates, despite being a treatable and preventable disease. The effectiveness of treatment depends on the continuous and adequate availability of anti-TB drugs, which must be not only effective but also of high quality. The results show that, although the difference in drug availability between the two countries is not very significant, there is a marked discrepancy in the number of patents associated with these drugs. The analysis of technological trends allows for an understanding of the implications of intellectual property protection on access to and availability of treatments. Understanding this gap and these disparities is essential for identifying opportunities and strengthening access to medications, as well as for supporting decision-makers in managing TB treatment